Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS
Biogen Inc. Data demonstrate potential of Manual Dexterity Test and Konectom™ smartphone-based technology in measuring MS disease progression Retrospective analysis applying machine learning, artificial intelligence and radiomics identifies brain imaging…